Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortSulfonylurea that boosts insulin release.Once-daily sulfonylurea.
Body systemDiabetes & WeightDiabetes & Weight
Drug classSulfonylureasSulfonylureas
SupplyPrescription onlyWHO essential medicinePrescription only
Main usesType 2 diabetesType 2 diabetes
How it worksTells your pancreas to release more insulin.Releases more insulin from the pancreas.
Starts working——
Half-life10–12 hours5–8 hours
Typical adult dose40–320 mg a day (split if over 160 mg); modified-release 30–120 mg once a day with breakfast.1–4 mg once a day with breakfast (maximum 6–8 mg).
FormsTablet, Modified-release tabletTablet, Combination tablets with metformin
Common side effectsLow blood sugar, Weight gain, Stomach upsetLow blood sugar, Weight gain, Dizziness
Serious side effectsSevere hypoglycaemia, Liver or blood problems (rare)Severe hypoglycaemia
Don't take ifType 1 diabetes or ketoacidosis; Severe kidney or liver impairment; Allergy to sulfonylureas; Taking miconazoleType 1 diabetes or ketoacidosis; Severe kidney or liver impairment; Allergy to sulfonylureas
AlcoholBest to limit. Alcohol raises the risk of severe low blood sugar.Best to limit. Alcohol raises the risk of severe low blood sugar.
PregnancyUsually avoidedUsually switched to insulin or metformin.Usually avoidedSwitch to insulin.
BreastfeedingUsually avoidedAvoid; insulin preferred.Usually avoidedAvoid; insulin preferred.
In use since19721995
Brand namesUnited Kingdom: Diamicron, ZicronIndia: Glizid, Reclide, DiamicronAustralia: Diamicron MRUnited States: AmarylUnited Kingdom: AmarylIndia: Amaryl, Glimy, Glimestar, Gemer (with metformin)
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC codeA10BB09A10BB12

Taken together

  • MinorGliclazide + Glimepiride: More risk of low blood sugar

    Both medicines lower blood sugar; combinations are common but hypos become more likely.

Open in the interaction checker